Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Share-based Compensation (2016 - 2025)

Marimed has reported Share-based Compensation over the past 11 years, most recently at $422000.0 for Q4 2025.

  • Quarterly Share-based Compensation rose 51.8% to $422000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 80.95% year-over-year, with the annual reading at $1.9 million for FY2025, 80.95% up from the prior year.
  • Share-based Compensation was $422000.0 for Q4 2025 at Marimed, up from $382000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $5.6 million in Q3 2021 and troughed at -$58000.0 in Q4 2022.
  • The 5-year median for Share-based Compensation is $339500.0 (2023), against an average of $950388.9.
  • The largest YoY upside for Share-based Compensation was 477.59% in 2023 against a maximum downside of 91.58% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $5.6 million in 2021, then crashed by 101.04% to -$58000.0 in 2022, then surged by 477.59% to $219000.0 in 2023, then increased by 26.94% to $278000.0 in 2024, then soared by 51.8% to $422000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Share-based Compensation are $422000.0 (Q4 2025), $382000.0 (Q3 2025), and $549000.0 (Q2 2025).